opioid discontinuation Archives

International Callers Dial 1-310-205-0808

FDA Addresses Discontinuation of Prescription Opioids

Waismann Method® Applauds FDA’s Opioid Label Changes but Cautions New Guidelines Are Not Enough BEVERLY HILLS, Calif., April 10, 2019 — The U.S. Food and Drug Administration’s recent efforts to stem the tide of the opioid epidemic have received backlash from pain management doctors and chronic pain patients. By curtailing access to prescription opioids for […]

We are available 7 days a week

Get Newsletter Updates from Waismann Method®

"*" indicates required fields

Email*

Name

By submitting this form, you expressly consent and agree to receive marketing and promotional emails from WAISMANN METHOD® Medical Group, located at 250 N. Robertson Blvd., Beverly Hills, CA, 90211, US, and its website https://www.opiates.com. You understand and acknowledge that you have the right to withdraw this consent and unsubscribe from receiving emails at any time by utilizing the SafeUnsubscribe® link, which is present at the bottom of every email sent to you. Please be advised that our emails are facilitated by Constant Contact. For more information on how we protect and handle your personal data, please review our Privacy Policy.

This field is for validation purposes and should be left unchanged.

DISCLAIMER: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional. Be advised that Opiates.com articles are derived from various sources and may not reflect your own country’s regulations.